Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 6 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Avadel Pharmaceuticals PLC (ADR) have a median target of 24.00, with a high estimate of 30.00 and a low estimate of 20.00. The median estimate represents a 76.47% increase from the last price of 13.60.
High | 120.6% | 30.00 |
Med | 76.5% | 24.00 |
Low | 47.1% | 20.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 06, 2024.
Average growth rate | +32.44% |
Average growth rate | -30.41% |
More ▼
Revenue history & estimates in USD
Average growth rate | +159.65% |
Average growth rate | -54.09% |
More ▼